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Background: The etiology of canine chronic bronchitis (CB) is not completely understood, although exposure to
environmental tobacco smoke (ETS) affects the airway inflammatory responses in some dogs with CB. The mechanism
by which this occurs is unknown.
Findings: We investigated the concentrations and methylation rates of free-floating DNA fragments in bronchoalveolar
lavage fluid (BALF) from dogs with chronic bronchitis. Based on serum cotinine levels, dogs with CB were divided into
2 groups: dogs that either had or had not been exposed to ETS. Our results demonstrated that the total nucleated cell
and macrophage numbers increased in BALF of ETS-exposed dogs with CB. There were no significant differences in
DNA concentrations and methylation rates in BALF between the 2 groups. However, 3 out of 8 dogs exposed to ETS
had high DNA methylation rates in their BALF samples.
Conclusion: Our results suggest that ETS exposure leads to epigenetic modifications of cellular components in BALF in
dogs diagnosed with CB.
Keywords: Chronic bronchitis, DNA methylation, Dog, Second-hand smokeFindings
Deoxyribonucleic acid (DNA) methylation is an epigenetic
modification that mainly occurs in CpG dinucleotides in
the CpG-rich islands located within gene promoter re-
gions. Methylation of CpG islands in promoter regions is
generally associated with gene silencing. Another epigen-
etic modification, DNA hypomethylation, is associated
with gene transcription [1]. The level of epigenetic DNA
methylation is considered to be an important factor in
the pathogenesis of various human diseases, including
pulmonary diseases such as lung cancer and chronic
obstructive pulmonary disease (COPD), a pulmonary
disorder associated with exposure to cigarette smoke
[2-4]. In humans, tobacco smoke exposure causes
changes, such as DNA methylation that are reversible* Correspondence: yamaya.yoshiki@nihon-u.ac.jp
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unless otherwise stated.and DNA mutations that are irreversible, to the epigen-
etic status [5-10].
In dogs, environmental tobacco smoke exposure (ETS)
plays a role in various smoking-related respiratory con-
ditions [11,12]. When mice were exposed to ETS, the
overall response was primarily global DNA hypomethy-
lation in the lung [13]. This finding is most consistent
with our current understanding of ETS-induced carcino-
genesis. In contrast, in cultured human airway epithelial
cells exposed to ETS, the induction of locoregional DNA
hypermethylation in the CpG-rich gene promoter region
was observed [14].
The etiology of canine chronic bronchitis (CB) is not
completely understood, although ETS exposure has add-
itional effects on the airway inflammatory responses in
some dogs with CB [12]. We examined the effect of ETS
exposure on airway inflammatory responses. We mea-
sured the concentrations and methylation rates of free-
floating DNA fragments in the bronchoalveolar lavagel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Results from bronchoalveolar lavage from dogs
with chronic bronchitis that had or had not been to
environmental tobacco smoke
Unexposed dogs Exposed dogs
Number 11 8
Males:Females 8:3 3:5
Age(y) 7.2 ± 2.5 8.6 ± 2.3
Serum cotinine
levels (ng/mL)




124 (57–231) 600 (100–3175)*
Macrophages (%), 56 (8–79) 73 (50–92)
(cells/μL) 56 (9–148) 438 (50–2921)*
Neutrophils (%), 21 (2–82) 12 (0–27)
(cells/μL) 30 (3–178) 26 (0–345)
Lymphocytes (%), 19 (3–54) 7 (0–36)
(cells/μL) 24 (2–78) 35 (0–870)
Eosinophils (%), 0 (0–4) 0 (0–3)
(cells/μL) 0 (0–4) 0 (0–20)
Total DNA concentrations
(ng/μL)
7.0 (3.3–20.2) 5.7 (2.4–29.4)
Corrected DNA concentrations
(ng/μL)
413 (158–1582) 478 (112–743)
Rates of DNA methylation (%) 11.4 (1.0–23.9) 17.0 (9.5–42.7)
*: significant differences between groups (p < 0.05).
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had not been exposed to ETS. We compared the
changes in these parameters between the two groups.
Methods
Nineteen dogs (4–12 years; 11 males and 8 females) di-
agnosed with CB were included in this study. Between
April 2005 and March 2010, these dogs had been referred
to the Animal Medical Center of Nihon University for
diagnoses and consultations for long-term therapy for
their clinical signs. The breeds included Miniature
Dachshund (n = 12), Shih Tzu (n = 2), and 1 each of
Pug, Maltese, Papillon, Shetland sheepdog, and mixed
breed. CB was diagnosed based on normal ranges of
blood test results, thickened bronchial walls on chest
X-ray and computed tomography, mucosal secretions,
and patterned indented surface in bronchoscopy. Total
nucleated cell counts were determined and the results
were used, provided the dogs did not present with other
nasal, throat, cardiac, infectious and neoplastic diseases.
Either an elevated total nucleated cell count (> = 400
cells/μL) with macrophage dominance (> = 50%) or nor-
mal total nucleated cell count (<400 cells/μL) with neu-
trophil dominance (> = 15%) in the BALF samples was
used as one of the parameters for the inclusion criteria.
All examinations were performed after informed con-
sent of the dogs’ owners under the guideline for the
care and use of laboratory animals by The College of
Bioresource Sciences, Nihon University.
Blood samples were collected from jugular veins as in
routine clinical examinations. Serum was isolated by
centrifugation and stored at −20°C until used for cotin-
ine measurements. Serum cotinine was determined
using a Cotinine Passive Smoking ELISA Kit (Cosmic
Corporation, Tokyo, Japan). BALF samples from the
dogs were obtained by gentle aspiration through a bi-
opsy channel of a bronchoscope after infusing sterile sa-
line (0.9% NaCl) solution (40 mL, divided into 2
aliquots) under general anesthesia with isoflurane. BALF
sample supernatants were isolated by centrifugation
(200 × g for 10 min) and immediately stored at −20°C
until DNA extraction. Free-floating DNA in 200 μL of
BALF supernatant was concentrated to 20 μL using a
DNA Extractor Kit (Wako, Japan). Concentrations of the
extracted DNA in sera and BALF samples were deter-
mined using a Nanodrop Spectrophotometer (NanoDrop
Technologies, USA) and corrected by urea concentra-
tions (QuantiChromTM Urea Assay Kit, BioAssay Sys-
tems, Hayward, CA, USA).
DNA methylation rates were determined with a
Methylamp Global DNA Methylation Quantification
Ultra Kit (Epigentek, USA) according to the manufac-
turer’s instructions. The capture antibody in this kit
binds to 5-methylcytosine. The total DNA methylationlevel was determined as a percentage of the total DNA
in a given sample. This technique measured the total
DNA fragments in the samples but not specific sites,
patterns, or methylation types. Samples were run in du-
plicate and points for the standard curve were run in
triplicate.
Medians with the range of minimum and maximum
values were used to express results. Group results were
compared by the Mann–Whitney rank sum test for non-
normally distributed variables. P values < 0.05 were con-
sidered significant. All statistical analyses were per-
formed using SigmaPlot for Windows, Version12.0
(Systat Software, Inc., San Jose, CA, USA).
Results
Based on serum cotinine levels, 19 dogs with CB were
divided into 2 groups: dogs who either had or had not
been exposed to ETS. Eleven dogs (4–12 years) not ex-
posed to ETS and 8 dogs (6–11 years) exposed to ETS
were analyzed. The results from their BALF samples
are shown in Table 1. Total nucleated cell counts and
the numbers of macrophages in BALF from dogs ex-
posed to ETS were significantly higher than those of
the dogs not exposed to ETS. There were no significant
differences in DNA concentration (P = 0.386), corrected
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(P = 0.076) in the BALF samples. The rate of DNA
methylation in 3 of the 8 dogs exposed to ETS was
higher than the range of that rate in dogs not exposed
to ETS (Table 1).
Discussion
It has been reported that acute tobacco smoke exposure
induced alveolar macrophage apoptosis [15]. If the
source of DNA fragments in BALF was alveolar macro-
phages, it would be expected that the DNA concentra-
tions in BALF would be higher in dogs exposed to ETS
than those not exposed to ETS. We found no differences
in the DNA concentrations in the BALF samples in ei-
ther group. In this study, the number of macrophages in
dogs exposed to ETS was higher than those in dogs not
exposed to ETS. This result is supported by the results
from a previous report, where the phagocytic activity of
macrophage was enhanced by ETS exposure in both
healthy dogs and those with CB [16].
Damaged airway epithelial cells may also be a consid-
erable source of free-floating DNA in BALF. Gene
hypermethylation occurs in the bronchial epithelium of
human smokers [5,10]. In human patients with COPD,
gene methylation was enhanced in the sputum, which
includes bronchial secretions with exfoliated cells from
the lower respiratory tract [17]. In addition, 20% of
atopic human patients develop asthma, which is usually
exacerbated by environmental factors including air pol-
lution or oxidative stress. DNA methylation in airway
epithelial cells was reduced in atopic children but in-
creased in asthmatic children with the histopathological
response in airway epithelial cells [18]. The enhanced
methylation of free-floating DNA fragments in BALF
may be linked with the histopathological damage in air-
way epithelial cells caused by ETS exposure in dogs with
CB [12].
The limitations of this study were the small sample
size and an unknown source of free-floating DNA frag-
ments in the BALF samples. In addition, there is no
available information regarding normal methylation
levels of free-floating DNA fragments in BALF from
clinically healthy adult dogs. It is possible that DNA
levels in BALF samples from healthy dogs may be un-
detectable or very low. Similar results were found in the
airway samples from healthy human subjects [17].
Conclusion
We conclude that ETS exposure may lead to epigenetic
modifications of cellular components in BALF from dogs
with CB. Further studies will be needed to determine the
location of genes with aberrant methylation patterns and
their therapeutic implications in dogs with CB that ei-
ther have or have not been exposed to ETS. Theophylineand β2-adrenergic agonists may be therapeutic and
beneficial for normalizing DNA methylation [2,19].
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